Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen Corporation

News   Aug 16, 2014

 
Miltenyi Biotec Acquires Gene Therapy Assets from Lentigen Corporation
 
 
 

RELATED ARTICLES

Boyds Acquires New Cambridge Office to Support Rapid Growth

News

Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.

READ MORE

Vaccines Are Not Protecting Farmed Fish From Disease

News

The vaccines used by commercial fish farmers are not protecting fish from disease, according to a new study. It showed vaccinated fish tend to show more symptoms when contracting diseases, with the health impacts and ultimately deaths occurring as if they’d never received a vaccine.

READ MORE

Uniqsis Reports on Expansion

News

Uniqsis reports following excellent business growth in 2017 that it has recruited a further sales / support specialist to be located at its office in Cambridge.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE